acetazolamide has been researched along with Myotonic Disorders in 2 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Myotonic Disorders: Diseases characterized by MYOTONIA, which may be inherited or acquired. Myotonia may be restricted to certain muscles (e.g., intrinsic hand muscles) or occur as a generalized condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stunnenberg, BC | 2 |
| LoRusso, S | 1 |
| Arnold, WD | 1 |
| Barohn, RJ | 1 |
| Cannon, SC | 1 |
| Fontaine, B | 1 |
| Griggs, RC | 1 |
| Hanna, MG | 1 |
| Matthews, E | 1 |
| Meola, G | 1 |
| Sansone, VA | 1 |
| Trivedi, JR | 1 |
| van Engelen, BGM | 1 |
| Vicart, S | 1 |
| Statland, JM | 1 |
| van Osch, T | 1 |
| Sternberg, D | 1 |
| Kerklaan, BJ | 1 |
1 review available for acetazolamide and Myotonic Disorders
| Article | Year |
|---|---|
Guidelines on clinical presentation and management of nondystrophic myotonias.
Topics: Acetazolamide; Age of Onset; Carbonic Anhydrase Inhibitors; Chloride Channels; Electrodiagnosis; Ele | 2020 |
1 other study available for acetazolamide and Myotonic Disorders
| Article | Year |
|---|---|
Prolonged attacks of weakness with hypokalemia in SCN4A-related paramyotonia congenita.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Electromyography; Humans; Hypokalemia; Male; Middle Ag | 2018 |